Home › Papillary Thyroid Cancer › NCT07140757
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Eligibility Criteria 1. Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC 2. Participant is over 18 years and is either not a surgical candidate or has declined surgery. 3. Capable and willing to provide written informed consent 4. Participant has one of the following diagnoses: * Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment, * Biopsy-proven indeterminate nodules (AUS or follicular neoplasm) * Papillary thyroid carcinoma (PTC) without metastasis * Locally recurrent thyroid cancer (\< 2 cm). Exclusion Criteria 1. Participants meeting any of the following criteria will be excluded: 2. Participants considered unsuitable for RFA by the treating physician
About the study
To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
What is being tested
- Questionnaire (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 50 · Started: Aug 18, 2025
Contact the study team
- Victoria E Banuchi, MD · Phone: 346-217-8668
Official record on ClinicalTrials.gov — NCT07140757
Locations in the U.S.
| Texas | MD Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.